These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15755740)

  • 1. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.
    Loiarro M; Sette C; Gallo G; Ciacci A; Fantò N; Mastroianni D; Carminati P; Ruggiero V
    J Biol Chem; 2005 Apr; 280(16):15809-14. PubMed ID: 15755740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
    Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
    J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
    Qin J; Qian Y; Yao J; Grace C; Li X
    J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
    Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
    J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
    Janssens S; Burns K; Tschopp J; Beyaert R
    Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta.
    Eto A; Muta T; Yamazaki S; Takeshige K
    Biochem Biophys Res Commun; 2003 Feb; 301(2):495-501. PubMed ID: 12565889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling.
    Bin LH; Xu LG; Shu HB
    J Biol Chem; 2003 Jul; 278(27):24526-32. PubMed ID: 12721283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses.
    Bartfai T; Behrens MM; Gaidarova S; Pemberton J; Shivanyuk A; Rebek J
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7971-6. PubMed ID: 12799462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIR domain-containing adaptors define the specificity of TLR signaling.
    Yamamoto M; Takeda K; Akira S
    Mol Immunol; 2004 Feb; 40(12):861-8. PubMed ID: 14698224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1.
    Jefferies C; Bowie A; Brady G; Cooke EL; Li X; O'Neill LA
    Mol Cell Biol; 2001 Jul; 21(14):4544-52. PubMed ID: 11416133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.